Oppenheimer & Co. Inc. Has $3.24 Million Stock Holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Oppenheimer & Co. Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 0.6% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 204,354 shares of the company’s stock after buying an additional 1,153 shares during the period. Oppenheimer & Co. Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $3,237,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Dakota Wealth Management raised its stake in BlackRock Health Sciences Term Trust by 5.3% during the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock worth $280,000 after acquiring an additional 915 shares in the last quarter. Brown Lisle Cummings Inc. lifted its stake in BlackRock Health Sciences Term Trust by 6.2% in the 3rd quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock valued at $578,000 after purchasing an additional 2,128 shares during the last quarter. Comerica Bank boosted its position in BlackRock Health Sciences Term Trust by 31.1% in the first quarter. Comerica Bank now owns 15,469 shares of the company’s stock valued at $254,000 after buying an additional 3,671 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its stake in shares of BlackRock Health Sciences Term Trust by 11.2% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 65,088 shares of the company’s stock worth $1,000,000 after buying an additional 6,565 shares during the last quarter. Finally, Register Financial Advisors LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 5,365.6% during the second quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock worth $105,000 after buying an additional 6,707 shares in the last quarter.

BlackRock Health Sciences Term Trust Price Performance

NYSE BMEZ opened at 15.26 on Friday. The business’s fifty day moving average is 15.78 and its 200 day moving average is 15.57. BlackRock Health Sciences Term Trust has a twelve month low of 13.53 and a twelve month high of 16.59.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be given a dividend of $0.1769 per share. This represents a $2.12 annualized dividend and a dividend yield of 13.91%. The ex-dividend date of this dividend is Friday, November 15th.

Insider Transactions at BlackRock Health Sciences Term Trust

In other news, major shareholder Saba Capital Management, L.P. purchased 15,455 shares of the company’s stock in a transaction that occurred on Thursday, September 19th. The stock was bought at an average cost of 16.14 per share, with a total value of 249,443.70. Following the completion of the purchase, the insider now owns 20,601,568 shares in the company, valued at approximately 332,509,307.52. This represents a 0.08 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Over the last quarter, insiders have purchased 99,630 shares of company stock valued at $1,585,113.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.